financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
Mar 4, 2024 11:01 PM

01:00 PM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target to $71 from $47 on a P/S of 7.5x, above its three-year average on good sales execution and a favorable deal pipeline, using our next-12-month sales estimate of $2.3B. We lift our FY 24 EPS view to $1.07 from $0.95 and FY 25's to $1.33 from $1.21. NTNX posted Q2 sales of $565.2M, above consensus by $14.8M, while non-GAAP EPS of $0.46 beat by $0.17. Revenue rose 16.2% Y/Y from solid Subscription revenue growth (+18% Y/Y) as ACV billings outperformed, up 23% Y/Y, from higher-than-anticipated renewals. We note NTNX's commentary around a continued uncertain macro environment, and longer average sales cycles, which likely impacted contract duration of 2.8 years in Q2, lower than Q1. However, these results reflect the firm's strong execution in securing and keeping pace with renewals and expansion deals, as well as maintaining healthy pricing levels in spite of these challenges. Its upbeat guidance and a higher mix of large deals in the pipeline further support our positive view of the business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Stifel Financial Corp. To Buy From Hold
Research Alert: CFRA Raises Opinion On Shares Of Stifel Financial Corp. To Buy From Hold
Apr 17, 2024
11:05 AM EDT, 04/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target price by $13 to $87, using a forward P/E of 13.0x our 2024 EPS estimate, a slight premium to SF's 10-year average multiple (12.5x) as we...
Research Alert: CFRA Reiterates Hold Opinion On Shares Of U.s. Bancorp
Research Alert: CFRA Reiterates Hold Opinion On Shares Of U.s. Bancorp
Apr 17, 2024
09:30 AM EDT, 04/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our 12-month target price by $1 to $41, 9.3x our 2025 EPS estimate, in line with the peer average of 9.2x. We lower our 2024 EPS view by...
Research Alert: CFRA Lifts Opinion On Shares Of Interactive Brokers To Strong Buy From Hold
Research Alert: CFRA Lifts Opinion On Shares Of Interactive Brokers To Strong Buy From Hold
Apr 17, 2024
08:20 AM EDT, 04/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After earnings beat, we lift our target price by $24 to $131 on a forward P/E of 19.9x our 2024 EPS estimate, in line with IBKR's five-year average multiple as...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Abbott Laboratories
Research Alert: CFRA Keeps Buy Opinion On Shares Of Abbott Laboratories
Apr 17, 2024
09:45 AM EDT, 04/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target at $126, 24.3x our 2025 EPS forecast, slightly above ABT's 10-year historical forward P/E average. We up our 2024 EPS view to $4.69 from $4.63, as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved